NCT00097487View on ClinicalTrials.gov

A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

September 30, 2004

Conditions
Breast CancerMetastases
Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00097487 - A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane | Biotech Hunter | Biotech Hunter